Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading

David H. Gutmann, Lawrence (Larry) Sherman, Liz Seftor, Carrie Haipek, Kimberly Hoang Lu, Mary Hendrix

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

The neurofibromatosis 2 (NF2) gene product, merlin, is a tumor suppressor protein mutated in schwannomas and several other tumors. Merlin, which shares significant homology with the actin-associated proteins ezrin, radixin and moesin (ERM proteins), inhibits cell growth when overexpressed in cell lines. The similarities between merlin and ERM proteins suggest that merlin's growth-regulatory capabilities may be due to alterations in cytoskeletal function. We examined this possibility in rat schwannoma cell lines overexpressing wild-type merlin isoforms and mutant merlin proteins. We found that overexpression of wild-type merlin resulted in transient alterations in F-actin organization, cell spreading and cell attachment. Merlin overexpression also impaired cell motility as measured in an in vitro motility assay. These effects were only observed in cells overexpressing a merlin isoform capable of inhibiting cell growth and not with mutant merlin molecules (NF2 patient mutations) or a merlin splice variant (isoform II) lacking growth-inhibitory activity. These data indicate that merlin may function to maintain normal cytoskeletal organization, and suggest that merlin's influence on cell growth depends on specific cytoskeletal rearrangements.

Original languageEnglish (US)
Pages (from-to)267-275
Number of pages9
JournalHuman Molecular Genetics
Volume8
Issue number2
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Neurofibromin 2
Neurofibromatosis 2
Tumor Suppressor Genes
Cell Adhesion
Cell Movement
Growth
Protein Isoforms
Neurilemmoma
Actins
Tumor Suppressor Proteins
Cell Line
Proteins
Mutant Proteins

ASJC Scopus subject areas

  • Genetics

Cite this

Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. / Gutmann, David H.; Sherman, Lawrence (Larry); Seftor, Liz; Haipek, Carrie; Lu, Kimberly Hoang; Hendrix, Mary.

In: Human Molecular Genetics, Vol. 8, No. 2, 1999, p. 267-275.

Research output: Contribution to journalArticle

Gutmann, David H. ; Sherman, Lawrence (Larry) ; Seftor, Liz ; Haipek, Carrie ; Lu, Kimberly Hoang ; Hendrix, Mary. / Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading. In: Human Molecular Genetics. 1999 ; Vol. 8, No. 2. pp. 267-275.
@article{108298ece1c54995b065f33a8c379dc8,
title = "Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading",
abstract = "The neurofibromatosis 2 (NF2) gene product, merlin, is a tumor suppressor protein mutated in schwannomas and several other tumors. Merlin, which shares significant homology with the actin-associated proteins ezrin, radixin and moesin (ERM proteins), inhibits cell growth when overexpressed in cell lines. The similarities between merlin and ERM proteins suggest that merlin's growth-regulatory capabilities may be due to alterations in cytoskeletal function. We examined this possibility in rat schwannoma cell lines overexpressing wild-type merlin isoforms and mutant merlin proteins. We found that overexpression of wild-type merlin resulted in transient alterations in F-actin organization, cell spreading and cell attachment. Merlin overexpression also impaired cell motility as measured in an in vitro motility assay. These effects were only observed in cells overexpressing a merlin isoform capable of inhibiting cell growth and not with mutant merlin molecules (NF2 patient mutations) or a merlin splice variant (isoform II) lacking growth-inhibitory activity. These data indicate that merlin may function to maintain normal cytoskeletal organization, and suggest that merlin's influence on cell growth depends on specific cytoskeletal rearrangements.",
author = "Gutmann, {David H.} and Sherman, {Lawrence (Larry)} and Liz Seftor and Carrie Haipek and Lu, {Kimberly Hoang} and Mary Hendrix",
year = "1999",
doi = "10.1093/hmg/8.2.267",
language = "English (US)",
volume = "8",
pages = "267--275",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading

AU - Gutmann, David H.

AU - Sherman, Lawrence (Larry)

AU - Seftor, Liz

AU - Haipek, Carrie

AU - Lu, Kimberly Hoang

AU - Hendrix, Mary

PY - 1999

Y1 - 1999

N2 - The neurofibromatosis 2 (NF2) gene product, merlin, is a tumor suppressor protein mutated in schwannomas and several other tumors. Merlin, which shares significant homology with the actin-associated proteins ezrin, radixin and moesin (ERM proteins), inhibits cell growth when overexpressed in cell lines. The similarities between merlin and ERM proteins suggest that merlin's growth-regulatory capabilities may be due to alterations in cytoskeletal function. We examined this possibility in rat schwannoma cell lines overexpressing wild-type merlin isoforms and mutant merlin proteins. We found that overexpression of wild-type merlin resulted in transient alterations in F-actin organization, cell spreading and cell attachment. Merlin overexpression also impaired cell motility as measured in an in vitro motility assay. These effects were only observed in cells overexpressing a merlin isoform capable of inhibiting cell growth and not with mutant merlin molecules (NF2 patient mutations) or a merlin splice variant (isoform II) lacking growth-inhibitory activity. These data indicate that merlin may function to maintain normal cytoskeletal organization, and suggest that merlin's influence on cell growth depends on specific cytoskeletal rearrangements.

AB - The neurofibromatosis 2 (NF2) gene product, merlin, is a tumor suppressor protein mutated in schwannomas and several other tumors. Merlin, which shares significant homology with the actin-associated proteins ezrin, radixin and moesin (ERM proteins), inhibits cell growth when overexpressed in cell lines. The similarities between merlin and ERM proteins suggest that merlin's growth-regulatory capabilities may be due to alterations in cytoskeletal function. We examined this possibility in rat schwannoma cell lines overexpressing wild-type merlin isoforms and mutant merlin proteins. We found that overexpression of wild-type merlin resulted in transient alterations in F-actin organization, cell spreading and cell attachment. Merlin overexpression also impaired cell motility as measured in an in vitro motility assay. These effects were only observed in cells overexpressing a merlin isoform capable of inhibiting cell growth and not with mutant merlin molecules (NF2 patient mutations) or a merlin splice variant (isoform II) lacking growth-inhibitory activity. These data indicate that merlin may function to maintain normal cytoskeletal organization, and suggest that merlin's influence on cell growth depends on specific cytoskeletal rearrangements.

UR - http://www.scopus.com/inward/record.url?scp=0032899713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032899713&partnerID=8YFLogxK

U2 - 10.1093/hmg/8.2.267

DO - 10.1093/hmg/8.2.267

M3 - Article

VL - 8

SP - 267

EP - 275

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 2

ER -